POSTER SESSION V
Wednesday, March 28, 2007   —  9:30 AM - 12:00 Noon
Exhibit Hall B - 1


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...

...then notice the 'Event Added' prompt
in the toolbar above as feedback:
 



HEMATOPATHOLOGY



Poster#Title and AuthorsItinerary
Planner
149 T Cell Marker Changes in Peripheral T Cell Lymphoma by Flow Cytometry Analysis (1219)
C Yue, A Anthony, H Bolton - US Labs, Irvine, CA
Add
150 CD20+ T-Cell Lymphoma: Clinicopathologic Features of 5 Cases (1175)
A Rahemtullah, NL Harris, JA Ferry - Massachusetts General Hospital, Boston, MA
Add
151 Primary Cutaneous CD4-Positive Small/Medium Sized Pleomorphic T-Cell Lymphoma: A Clonal T Cell Lymphoproliferative Disorder with Indolent Behavior (1107)
KL Grogg, S Jung, LA Erickson, A Dogan - Mayo Clinic, Rochester, MN
Add
152 Proteomic Analysis of PKC-Inhibitor Mediated Changes in NPM/ALK-Positive ALCL (1194)
CM Sjostrom, DK Crockett, CE Seiler, KSJ Elenitoba-Johnson, MS Lim - University of Utah School of Medicine, Salt Lake City, UT; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT; University of Michigan, Ann Arbor, MI
Add
153 Anaplastic Large Cell Lymphoma in Vicinity to Breast Implant: Histologic, Immunophenotypic, Molecular Genetic Studies and Clinical Follow-Up of Three Cases (1182)
AC Roden, WR Macon, GL Keeney, JL Myers, A Dogan - Mayo Clinic, Rochester, MN; University of Michigan Health System, Ann Arbor, MI
Add
154 Germinal Center T Helper Cell Markers PD-1 and CXCL13 Are Both Expressed by Neoplastic Cells in Angioimmunoblastic Lymphoma (1218)
H Yu, A Shahsafaei, DM Dorfman - - Brigham and Women’s Hospital, Boston, MA
Add
155 Histological and Immunophenotypical Characterization of Angioimmunoblastic T-Cell Lymphoma (AILT) Involving the Bone Marrow (1199)
MAL Tan, W Chen, D Jones, V Leventaki, LJ Medeiros, F Vega - UT MD Anderson Cancer Center, Houston, TX
Add
156 Angioimmunoblastic T-Cell Lymphoma: A Tissue Microarray Analysis (1081)
P Chandra, X Zhang, L Chiriboga, S Ibrahim - New York University School of Medicine, New York, NY
Add
157 T-Cell Large Granular Lymphocytic Leukemia Associated with Myelodysplastic Syndrome (1122)
YO Huh, F Ravandi, A Aribi, L Chen, S Konoplev, J Jorgensen, D Jones, LV Abruzzo, LJ Medeiros - University of Texas M. D. Anderson Cancer Center, Houston, TX
Add
158 CD26 Expression in Neoplastic and Reactive T-Cell Processes in Tissue and Body Fluid Specimens (1171)
DM Pierson, D Jones, LJ Medeiros, JL Jorgensen - MD Anderson Cancer Center, Houston, TX
Add
159 Differential Expression of the ID2 Helix-Loop-Helix Protein in T-Cell Lymphomas (1090)
CV Cotta, V Leventaki, A Vidaki, LJ Medeiros, GZ Rassidakis - UT MDACC, Houston, TX
Add
160 B-Cell Heavy Chain Gene Rearrangement in Classical Hodgkin Lymphoma (1195)
LB Smith, B Schnitzer, HC Weigelin, JA Thorson - University of Michigan, Ann Arbor, MI
Add
161 Downregulation of the Tumor Suppressor Gene PRDM1/Blimp-1 by Putative Oncogenic MicroRNAs in Hodgkin/Reed-Sternberg Cells (1163)
K Nie, MF Gomez, P Landgraf, JF Garcia, A Chadburn, YF Liu, LHC Tan, T Tuschl, DM Knowles, W Tam - Weill Cornell Medical College, New York, NY; The Rockefeller University, New York, NY; Spanish National Cancer Center, Madrid, Spain; Singapore General Hospital, Singapore
Add
162 Aberrant Expression of Epstein-Barr Virus Latent Membrane Protein 1 and Cyclin A in Hodgkin Lymphoma: Implications for the Morphogenesis of Hodgkin, Reed-Sternberg, and Mummified Cells (1082)
KC Chang, PCH Chen, D Jones, IJ Su - National Cheng Cheng Kung University Hospital, Tainan, Taiwan; Veterans General Hospital-Taipei, Taipei, Taiwan; University of Texas M.D. Anderson Cancer Center, Houston, TX
Add
163 NAT-105, a New Marker for Follicular T-Cells, Useful for the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma (1160)
SH Nam-Cha, G Roncador, S Montes-Moreno, L Sanchez-Verde, MA Piris - Spanish National Cancer Centre, Madrid, Spain
Add
164 Primary Lung Lymphomas: A Clinicopathologic Analysis of 61 Cases, Focusing on Immunophenotype, Cytogenetics and Molecular Genetics (1140)
P Kotsali, SK Barta, PA Hamlin, J Teruya-Feldstein, DA Filippa - Memorial Sloan Kettering Cancer Center, New York, NY
Add
165 Clinicopathologic Analysis of 94 Cases of Breast Lymphomas (1198)
SS Talwalkar, JR Valbuena, GZ Rassidakis, LJ Medeiros, AW Martin - University of Louisville, Louisville, KY; UT MD Anderson Cancer Center, Houston, TX
Add
166 B-Cell Lymphomas with Marked Tissue Eosinophilia and Plasmacytoid Differentiation, a Study of 25 Cases (1073)
S Bian, L Jiang, A Vivero, S Pittaluga, M Raffeld, ES Jaffe - NIH, Bethesda, MD; Singapore General Hospital, Singapore City, Singapore, Singapore
Add
167 Analysis of 6q Deletion in Waldenstrom Macroglobulinemia (1174)
C Qi, W Xu, JC Reader, Y Ning, H Chang - University Health Network and Dept of Lab Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada; University of Maryland, MD
Add
168 Residual Plasma Cell Monoclonality in Lymphoplasmacytic Lymphoma after Treatment with Rituximab (1207)
EX Wei, P Lin, CE Bueso-Ramos, LJ Medeiros, LJ Jorgensen - UT MD Anderson Cancer Center, Houston, TX
Add
169 Lymphomas in Patients with Rheumatoid Arthritis: A Clinicopathologic Investigation of 28 Cases (1087)
WWL Choi, X Shi, JA Stoner, K Fu, JO Endo, JO Armitage, TR Mikuls, P Aoun - University of Nebraska Medical Center, Omaha, NE; University of Wisconsin, Madison, WI
Add
170 CXCL13 Expression Patterns in B-Cell Non-Hodgkin Lymphomas (1170)
LL Pate, Y Natkunam, TI George - Stanford University, Stanford, CA
Add
171 GCET1 (Centerin) a New Highly Restricted Marker for Germinal Center B Cells. Immunohistochemical Investigation of Its Expression in Lymphoid Neoplasms (1158)
S Montes-Moreno, G Roncador, L Maestre, L Sanchez-Verde, C Murillo-Lazaro, P Conesa-Zamora, JF Garcia, FI Camacho, Y Shen, WC Chan, MA Piris - Spanish National Cancer Centre, Madrid, Spain; University of Nebraska Medical Centre, Omaha, NE
Add
172 Low nm23-H1 Expression Correlates with Clinical Aggressiveness of B-Cell Non-Hodgkin Lymphomas (1074)
S Bircan, KV Inamdar, GZ Rassidakis, LJ Medeiros - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Add
173 Serine 194-Phoshorylated FADD Is Differentially Expressed and Correlates with Cell Proliferation in B-Cell Non-Hodgkin Lymphomas (1095)
E Drakos, E Schlette, P Lin, LJ Medeiros, GZ Rassidakis - The University of Texas M.D. Anderson Cancer Center, Houston, TX
Add
174 Fibroblast Growth Factor Receptor 3 Expression in Non-Hodgkin Lymphoma (1143)
A Larson, JR Cook - Cleveland Clinic, Cleveland, OH
Add
175 Sphingosine Kinase 1 Protein and mRNA Is Highly Expressed in B-Cell NHL and Is a Potential Target for Pharmacological Inhibition (1072)
MG Bayerl, A Abou-Elella, RD Bruggeman, E Conroy, JA Hengst, M Jiminez, JK Yun - Penn State College of Medicine, Hershey, PA
Add
176 Eleven-Parameter Flow Cytometry of Lymphoma-Infiltrating T Lymphocytes: Expansion of Memory and Suppressor/Regulatory T Cells (1190)
AC Seegmiller, RW McKenna, NJ Karandikar - UT Southwestern Medical Center, Dallas, TX
Add
177 Novel Monoclonal Antibodies to Human Kappa and Lambda Immunoglobulin Light Chains Suitable for Immunohistochemical Staining and Direct Immunofluorescence Microscopy on Formalin-Fixed, Paraffin-Embedded (FFPE) Tissues (1197)
SI Syrbu, OW Rokhlin, MB Cohen - University of Iowa, Iowa City, IA
Add
178 The Utilization of STR-PCR Testing To Determine Donor Versus Host Origin of Post Transplant Lymphoproliferative Disorders Arising in Solid Organ Transplants (1181)
B Richendollar, J Pettay, J Starbuck, D Cook, RR Tubbs, ED Hsi - Cleveland Clinic, Cleveland, OH
Add